The Revolving Door. Round and round she goes, where she stops, no one knows.
On January 15, Dr. Scott Gottlieb leaves the FDA as Deputy Commissioner for Medical and Scientific Affairs, returning to his old haunts at the ultra conservative American Enterprise Institute (AEI). Gottlieb was at FDA for about a year and continued to practice medicine on the side, while there. Very demanding job. Practicing medicine. (See posts here and here.)
His replacement has just been announced by newly confirmed FDA Commissioner Dr. Andrew von Eschenbach. It is Randall Lutter, Ph.D., who will serve as Acting Deputy Commissioner for Policy. While the title is different, the announcement says he is replacing Gottlieb.
Lutter has played a key role at the FDA in keeping Americans safe from those cheap imported drugs from Canada. He’s been with FDA since 2003. Where was he before that? He was a resident scholar with . . . (drum roll)
The American Enterprise Institute.